Literature DB >> 25263453

Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.

D Merino1, S A Best1, M-L Asselin-Labat1, F Vaillant1, B Pal1, R A Dickins1, R L Anderson2, A Strasser1, P Bouillet1, G J Lindeman3, J E Visvader1.   

Abstract

Evasion of cell death is fundamental to the development of cancer and its metastasis. The role of the BCL-2-mediated (intrinsic) apoptotic program in these processes remains poorly understood. Here we have investigated the relevance of the pro-apoptotic protein BIM to breast cancer progression using the MMTV-Polyoma middle-T (PyMT) transgenic model. BIM deficiency in PyMT females did not affect primary tumor growth, but substantially increased the survival of metastatic cells within the lung. These data reveal a role for BIM in the suppression of breast cancer metastasis. Intriguingly, we observed a striking correlation between the expression of BIM and the epithelial to mesenchymal transition transcription factor SNAI2 at the proliferative edge of the tumors. Overexpression and knockdown studies confirmed that these two genes were coordinately expressed, and chromatin immunoprecipitation analysis further revealed that Bim is a target of SNAI2. Taken together, our findings suggest that SNAI2-driven BIM-induced apoptosis may temper metastasis by governing the survival of disseminating breast tumor cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25263453     DOI: 10.1038/onc.2014.313

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

1.  Chromatin immunoprecipitation of mouse embryos.

Authors:  Anne K Voss; Mathew P Dixon; Tamara McLennan; Andrew J Kueh; Tim Thomas
Journal:  Methods Mol Biol       Date:  2012

2.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

3.  Polycystic kidney disease prevented by transgenic RNA interference.

Authors:  P Bouillet; M Robati; M Bath; A Strasser
Journal:  Cell Death Differ       Date:  2005-07       Impact factor: 15.828

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

5.  Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.

Authors:  Samantha R Oakes; François Vaillant; Elgene Lim; Lily Lee; Kelsey Breslin; Frank Feleppa; Siddhartha Deb; Matthew E Ritchie; Elena Takano; Teresa Ward; Stephen B Fox; Daniele Generali; Gordon K Smyth; Andreas Strasser; David C S Huang; Jane E Visvader; Geoffrey J Lindeman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.

Authors:  Xiao-Jun Qi; Gary M Wildey; Philip H Howe
Journal:  J Biol Chem       Date:  2005-11-10       Impact factor: 5.157

7.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.

Authors:  Mauricio J Reginato; Kenna R Mills; Jessica K Paulus; Danielle K Lynch; Dennis C Sgroi; Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

9.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 10.  Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency.

Authors:  A F Chambers; G N Naumov; S A Vantyghem; A B Tuck
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

View more
  13 in total

Review 1.  Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.

Authors:  D Merino; S W Lok; J E Visvader; G J Lindeman
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

Review 2.  Mitochondrial Involvement in Migration, Invasion and Metastasis.

Authors:  Tatiana V Denisenko; Anna S Gorbunova; Boris Zhivotovsky
Journal:  Front Cell Dev Biol       Date:  2019-12-20

3.  Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

Authors:  Meng Wang; Jing Han; Lynnette Marcar; Josh Black; Qi Liu; Xiangyong Li; Kshithija Nagulapalli; Lecia V Sequist; Raymond H Mak; Cyril H Benes; Theodore S Hong; Kristin Gurtner; Mechthild Krause; Michael Baumann; Jing X Kang; Johnathan R Whetstine; Henning Willers
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

4.  Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy.

Authors:  Pingchuan Ma; Jingmei Li; Yan Gao; Jieping Wu; Ke Men; Chunjie Li; Yi Men; Xingmei Duan
Journal:  Int J Nanomedicine       Date:  2022-07-04

Review 5.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

6.  A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1.

Authors:  Julie M Sheridan; Matthew E Ritchie; Sarah A Best; Kun Jiang; Tamara J Beck; François Vaillant; Kevin Liu; Ross A Dickins; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

7.  Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung Carcinoma.

Authors:  Jun Atsumi; Kimihiro Shimizu; Yoichi Ohtaki; Kyoichi Kaira; Seiichi Kakegawa; Toshiteru Nagashima; Yasuaki Enokida; Seshiru Nakazawa; Kai Obayashi; Yoshiaki Takase; Osamu Kawashima; Mitsuhiro Kamiyoshihara; Masayuki Sugano; Takashi Ibe; Hitoshi Igai; Izumi Takeyoshi
Journal:  J Glob Oncol       Date:  2015-12-23

8.  Inhibition of Cdk5 induces cell death of tumor-initiating cells.

Authors:  Melanie M Mandl; Siwei Zhang; Melanie Ulrich; Elisa Schmoeckel; Doris Mayr; Angelika M Vollmar; Johanna Liebl
Journal:  Br J Cancer       Date:  2017-02-21       Impact factor: 7.640

9.  Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Zhenghua Zhang; Tao Huang; Yu-Dong Cai
Journal:  Mol Ther Methods Clin Dev       Date:  2018-06-21       Impact factor: 6.698

10.  Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.

Authors:  Jasmine A McQuerry; David F Jenkins; Susan E Yost; Yuqing Zhang; Daniel Schmolze; W Evan Johnson; Yuan Yuan; Andrea H Bild
Journal:  BMC Cancer       Date:  2019-09-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.